TY  - JOUR

T1  - Cost-efficacy in interventional cardiology; results from the EPISTENT study. Evaluation of Platelet IIb/IIIa Inhibitor For Stenting Trial.

JO  - Eur Heart J

PY  - 2001/08/01

AU  - Zwart-van Rijkom JE

AU  - van Hout BA

ED  - 

DO  - DOI: 10.1053/euhj.2000.2543

VL  - 22

IS  - 16

SP  - 1476

EP  - 1484

Y2  - 2024/12/22

ER  -